The mechanism of treating atopic dermatitis with black bean distillate oil was studied based on the combination of network pharmacology and omics
Atopic dermatitis (AD) is a common inflammatory skin disease characterized by chronic pruritus, skin barrier dysfunction, and immune abnormalities. This project aims to systematically study the molecular mechanism of black bean distillate in the treatment of AD through modern techniques such as network pharmacology, molecular docking and metabolomics, and develop new drugs with independent intellectual property rights.